Skin and lung fibrosis induced by bleomycin in mice: a systematic review

Objective. Scleroderma, or systemic sclerosis (SSc), is a chronic autoimmune connective disease with an unknown etiology and poorly understood pathogenesis. The striking array of autoimmune, vascular, and fibrotic changes that develop in almost all patients makes SSc unique among connective tissue...

Full description

Bibliographic Details
Main Authors: S. Gülle, A. Çelik, M. Birlik, O. Yılmaz
Format: Article
Language:English
Published: PAGEPress Publications 2024-03-01
Series:Reumatismo
Subjects:
Online Access:https://www.reumatismo.org/reuma/article/view/1642
_version_ 1797248671434145792
author S. Gülle
A. Çelik
M. Birlik
O. Yılmaz
author_facet S. Gülle
A. Çelik
M. Birlik
O. Yılmaz
author_sort S. Gülle
collection DOAJ
description Objective. Scleroderma, or systemic sclerosis (SSc), is a chronic autoimmune connective disease with an unknown etiology and poorly understood pathogenesis. The striking array of autoimmune, vascular, and fibrotic changes that develop in almost all patients makes SSc unique among connective tissue diseases. Although no animal model developed for SSc to date fully represents all features of human disease, some animal models that demonstrate features of SSc may help to better understand the pathogenesis of the disease and to develop new therapeutic options. In this review, we aimed to evaluate skin fibrosis and lung involvement in a bleomycin (BLM)-induced mouse model and to evaluate the differences between studies. Methods. A systematic literature review (PRISMA guideline) on PubMed and EMBASE (until May 2023, without limits) was performed. A primary literature search was conducted using the PubMed and EMBASE databases for all articles published from 1990 to May 2023. Review articles, human studies, and non-dermatological studies were excluded. Of the 38 non-duplicated studies, 20 articles were included. Results. Among inducible animal models, the BLM-induced SSc is still the most widely used. In recent years, the measurement of tissue thickness between the epidermal-dermal junction and the dermal-adipose tissue junction (dermal layer) has become more widely accepted. Conclusions. In animal studies, it is important to simultaneously evaluate lung tissues in addition to skin fibrosis induced in mice by subcutaneous BLM application, following the 3R (replacement, reduction, and refinement) principle to avoid cruelty to animals.
first_indexed 2024-04-24T20:18:18Z
format Article
id doaj.art-3f03d72e557c4107acfffdacb90f2aae
institution Directory Open Access Journal
issn 0048-7449
2240-2683
language English
last_indexed 2024-04-24T20:18:18Z
publishDate 2024-03-01
publisher PAGEPress Publications
record_format Article
series Reumatismo
spelling doaj.art-3f03d72e557c4107acfffdacb90f2aae2024-03-22T13:03:50ZengPAGEPress PublicationsReumatismo0048-74492240-26832024-03-0176110.4081/reumatismo.2024.1642Skin and lung fibrosis induced by bleomycin in mice: a systematic reviewS. Gülle0A. Çelik1M. Birlik2O. Yılmaz3Division of Rheumatology, Department of Internal Medicine, Dokuz Eylul University School of Medicine, Izmir; Department of Laboratory Animal Science, Dokuz Eylul University School of Medicine, IzmirDepartment of Laboratory Animal Science, Dokuz Eylul University School of Medicine, IzmirDivision of Rheumatology, Department of Internal Medicine, Dokuz Eylul University School of Medicine, IzmirDepartment of Laboratory Animal Science, Dokuz Eylul University School of Medicine, Izmir Objective. Scleroderma, or systemic sclerosis (SSc), is a chronic autoimmune connective disease with an unknown etiology and poorly understood pathogenesis. The striking array of autoimmune, vascular, and fibrotic changes that develop in almost all patients makes SSc unique among connective tissue diseases. Although no animal model developed for SSc to date fully represents all features of human disease, some animal models that demonstrate features of SSc may help to better understand the pathogenesis of the disease and to develop new therapeutic options. In this review, we aimed to evaluate skin fibrosis and lung involvement in a bleomycin (BLM)-induced mouse model and to evaluate the differences between studies. Methods. A systematic literature review (PRISMA guideline) on PubMed and EMBASE (until May 2023, without limits) was performed. A primary literature search was conducted using the PubMed and EMBASE databases for all articles published from 1990 to May 2023. Review articles, human studies, and non-dermatological studies were excluded. Of the 38 non-duplicated studies, 20 articles were included. Results. Among inducible animal models, the BLM-induced SSc is still the most widely used. In recent years, the measurement of tissue thickness between the epidermal-dermal junction and the dermal-adipose tissue junction (dermal layer) has become more widely accepted. Conclusions. In animal studies, it is important to simultaneously evaluate lung tissues in addition to skin fibrosis induced in mice by subcutaneous BLM application, following the 3R (replacement, reduction, and refinement) principle to avoid cruelty to animals. https://www.reumatismo.org/reuma/article/view/1642Sclerodermamurinebleomycinskin thicknesspulmonary fibrosisanimal model
spellingShingle S. Gülle
A. Çelik
M. Birlik
O. Yılmaz
Skin and lung fibrosis induced by bleomycin in mice: a systematic review
Reumatismo
Scleroderma
murine
bleomycin
skin thickness
pulmonary fibrosis
animal model
title Skin and lung fibrosis induced by bleomycin in mice: a systematic review
title_full Skin and lung fibrosis induced by bleomycin in mice: a systematic review
title_fullStr Skin and lung fibrosis induced by bleomycin in mice: a systematic review
title_full_unstemmed Skin and lung fibrosis induced by bleomycin in mice: a systematic review
title_short Skin and lung fibrosis induced by bleomycin in mice: a systematic review
title_sort skin and lung fibrosis induced by bleomycin in mice a systematic review
topic Scleroderma
murine
bleomycin
skin thickness
pulmonary fibrosis
animal model
url https://www.reumatismo.org/reuma/article/view/1642
work_keys_str_mv AT sgulle skinandlungfibrosisinducedbybleomycininmiceasystematicreview
AT acelik skinandlungfibrosisinducedbybleomycininmiceasystematicreview
AT mbirlik skinandlungfibrosisinducedbybleomycininmiceasystematicreview
AT oyılmaz skinandlungfibrosisinducedbybleomycininmiceasystematicreview